Directory
>
Mohammad Shadid
Mohammad Shadid
Vice President, Translational Sciences | Korro Bio, Inc.
Cambridge, Massachusetts, United States
Mohammad Shadid
Summary
Mohammad Shadid is a seasoned executive in the pharmaceutical industry, currently serving as Vice President and Head of Translational Sciences at Korro Bio. With a strong background in drug metabolism and pharmacokinetics, he has successfully led the transition of drug assets from early research to phase 1 clinical trials, coauthoring crucial regulatory submissions. His leadership in managing multiple CROs and overseeing significant budgets highlights his project management expertise. Mohammad is also recognized for his commitment to diversity, inclusion, and equity within organizations, demonstrating a holistic approach to leadership. His academic credentials, including a Ph.D. in Drug Metabolism and Pharmacokinetics, underpin his technical expertise. He has authored numerous publications, contributing to advancements in drug development and safety assessments. His strategic insight and cross-functional collaboration have made significant impacts on therapeutic pipelines.
Mohammad Shadid
Work Experience
Vice President, Translational Sciences at
Korro Bio, Inc.
January 2023 - Present
Executive Director, Head of Nonclinical Development at
Aruvant
January 2022 - January 2023
Senior Director-Nonclinical Development at
Aruvant
January 2021 - January 2022
Translational Development Lead at
Sarepta Therapeutics
January 2019 - January 2021
Nonclinical Development Lead at
Sarepta Therapeutics
January 2018 - January 2019
DMPK Lead at
Biogen
January 2016 - January 2017
Scientist: Drug Metabolism & Pharmacokinetics (DMPK) at
Takeda Pharmaceuticals America, Inc.
January 2008 - January 2016
Mohammad Shadid
Education
Cornell Johnson Graduate School of Management, Master Of Business Administration (Mba)
The University of Utah, Ph.D
Middle Tennessee State University, Masters
Jordan University of Science and Technology, Applied Chemistry
Frequently Asked Questions about Mohammad Shadid
What is Mohammad Shadid email address?
Mohammad Shadid's primary email address is ******@mpi.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mohammad Shadid work for?
Mohammad Shadid is a Vice President, Translational Sciences at Korro Bio, Inc., a company specializing in Commercial physical research.
Where Mohammad Shadid graduated from?
Mohammad Shadid holds a degree in Strategy, General Management from Cornell Johnson Graduate School of Management.
How can I directly contact Mohammad Shadid?
To contact Mohammad Shadid directly, you can use the email address ******@mpi.com. Complete contact information is available upon registration with Muraena.
Who is Mohammad Shadid?
Mohammad Shadid is a seasoned executive in the pharmaceutical industry, currently serving as Vice President and Head of Translational Sciences at Korro Bio. With a strong background in drug metabolism and pharmacokinetics, he has successfully led the transition of drug assets from early research to phase 1 clinical trials, coauthoring crucial regulatory submissions. His leadership in managing multiple CROs and overseeing significant budgets highlights his project management expertise. Mohammad is also recognized for his commitment to diversity, inclusion, and equity within organizations, demonstrating a holistic approach to leadership. His academic credentials, including a Ph.D. in Drug Metabolism and Pharmacokinetics, underpin his technical expertise. He has authored numerous publications, contributing to advancements in drug development and safety assessments. His strategic insight and cross-functional collaboration have made significant impacts on therapeutic pipelines.
Mohammad`s contact details
******@mpi.com
***************@takeda.com
****@korrobio.com
Colleagues
VP, Head of CMC
SVP, HR People & Culture
Director Board of Directors
Vice President
Senior Vice President, Strategy And Portfolio Planning
Consultant
Vice President, Head of CNS Biology
Vice President, Corporate Strategy & Portfolio Planning
Senior Vice President, Head of Platform Research - RNA Editing
Chief Financial Officer